Phase 3 clinical trial results lead to approval of oral drug for red blood cell disorder: ACTIVATE…
Researchers have published the results of a clinical trial that led the U.S. Food and Drug Administration to recently approve mitapivat for the treatment of adults with pyruvate kinase deficiency -- a rare genetic condition that leads to…